Safety and effectiveness of haloperidol for mentally retarded behaviorally disordered and hyperkinetic patients.
D000293:Adolescent; D000328:Adult; D000342:Affective Symptoms / Q000188:drug therapy; D000368:Aged; D001590:Benztropine / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy*; D008607:Intellectual Disability / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D001590:Benztropine; D006220:Haloperidol